Figure 3.(A) The relationship between sarcopenia and ORR in TAE or TACE treated HCC patients; (B) The relationship between sarcopenia and DCR in TAE or TACE treated HCC patients.
Figure 3 — The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients | Aging
